Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents.
Ratain
M J
MJ
Department of Medicine, University of Chicago Pritzker School of Medicine, Ill.
Mick
R
R
Schilsky
R L
RL
Siegler
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic / Q000592:standards*; D017322:Clinical Trials, Phase II as Topic / Q000592:standards*; D032962:Consent Forms; D030881:Disclosure; D004992:Ethics, Medical; D006801:Humans; D007258:Informed Consent; D033281:Nontherapeutic Human Experimentation; D018579:Patient Selection; D026684:Personal Autonomy; D012107:Research Design / Q000592:standards*; D035842:Research Subjects; D018570:Risk Assessment; D013223:Statistics as Topic; D036302:Therapeutic Human Experimentation; D014481:United States
D000970:Antineoplastic Agents